Nanobiotix announces the appointment of Louis Kayitalire as Chief Medical Officer, who will bring to the company 'outstanding biopharmaceutical industry expertise marked by successful projects' in the field of oncology.

Prior to joining Nanobiotix, he was Chief Medical Officer of F-star Biotechnology, a biotech company specializing in immuno-oncology with a bispecific monoclonal antibody platform.

During his career, Louis Kayitalire has also held senior positions at Bristol-Myers Squibb, Celgene and Eli Lilly, where he contributed to the registration of Gemzar, Alimta, Erbitux and Opdivo.

Copyright (c) 2023 CercleFinance.com. All rights reserved.